Paliwal Diagnostics Profile
Key Indicators
- Authorised Capital ₹ 0.40 M
as on 23-12-2024
- Paid Up Capital ₹ 0.20 M
as on 23-12-2024
- Company Age 27 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 2.86 M
as on 23-12-2024
- Revenue 15.63%
(FY 2024)
- Profit 32.35%
(FY 2024)
- Ebitda 24.13%
(FY 2024)
- Net Worth 25.93%
(FY 2024)
- Total Assets 24.38%
(FY 2024)
About Paliwal Diagnostics
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.40 M and a paid-up capital of Rs 0.20 M.
The company has closed loans amounting to ₹2.86 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Arvind Lal, Umesh Paliwal, and Shankha Banerjee serve as directors at the Company.
- CIN/LLPIN
U26914UP1997PTC022257
- Company No.
022257
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Jul 1997
- Date of AGM
27 Jun 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Kanpur Nagar, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
- Apps
Who are the key members and board of directors at Paliwal Diagnostics?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arvind Lal  | Director | 14-Aug-2008 | Current |
| Umesh Paliwal | Director | 01-Dec-1997 | Current |
| Shankha Banerjee | Director | 26-Oct-2017 | Current |
Financial Performance of Paliwal Diagnostics.
Paliwal Diagnostics Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 15.63% increase. The company also saw a substantial improvement in profitability, with a 32.35% increase in profit. The company's net worth Soared by an impressive increase of 25.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Paliwal Diagnostics?
In 2024, Paliwal Diagnostics had a promoter holding of 80.00% and a public holding of 20.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Suburban Diagnostics (India) Private LimitedActive 22 years 7 monthsShankha Banerjee is a mutual person
- Pathlabs Unifiers Private LimitedActive 6 years 1 month
Arvind Lal and Shankha Banerjee are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 16 Mar 2005 | ₹0.69 M | Satisfied |
State Bank Of India Creation Date: 22 Jul 2003 | ₹0.32 M | Satisfied |
State Bank Of India Creation Date: 04 Jun 2002 | ₹0.85 M | Satisfied |
How Many Employees Work at Paliwal Diagnostics?
Paliwal Diagnostics has a workforce of 212 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Paliwal Diagnostics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Paliwal Diagnostics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
